RT @synovialjoints: Initial use of glucocorticoids GC as bridging treatment in RA resulted in increase use of GC later,

Initial use of glucocorticoids GC as bridging treatment in RA resulted in increase use of GC later, fewer DMARD changes later, van Ouwerkek L, Abst#OP220 #EULAR2023 @RheumNow https://t.co/IjxgQTZ8SE